Inotek’s Southwell and McVicar Have Designs on Treating Glaucoma
Inotek CEO David Southwell and William K. McVicar Ph.D. Executive Vice President, Chief Scientific Officer, share Inotek’s plan to bring to market a new first-line for glaucoma sufferers.
Activity